Literature DB >> 33260126

Ambulatory neurosurgery in the COVID-19 era: patient and provider satisfaction with telemedicine.

Alina Mohanty1, Visish M Srinivasan1, Jan-Karl Burkhardt1, Jeremiah Johnson1, Akash J Patel1, Sameer A Sheth1, Ashwin Viswanathan1, Daniel Yoshor1, Peter Kan2.   

Abstract

OBJECTIVE: Telemedicine has rapidly expanded in the recent years as technologies have afforded healthcare practitioners the ability to diagnose and treat patients remotely. Due to the COVID-19 pandemic, nonessential clinical visits were greatly limited, and much of the outpatient neurosurgical practice at the authors' institution was shifted quickly to telehealth. Although there are prior data suggesting that the use of telemedicine is satisfactory in other surgical fields, data in neurosurgery are limited. This study aimed to investigate both patient and provider satisfaction with telemedicine and its strengths and limitations in outpatient neurosurgery visits.
METHODS: This quality improvement study was designed to analyze provider and patient satisfaction with telemedicine consultations in an outpatient neurosurgery clinic setting at a tertiary care, large-volume, academic center. The authors designed an 11-question survey for neurosurgical providers and a 13-question survey for patients using both closed 5-point Likert scale responses and multiple choice responses. The questionnaires were administered to patients and providers during the period when the clinic restricted in-person visits. At the conclusion of the study, the overall data were analyzed qualitatively and quantitatively.
RESULTS: During the study period, 607 surveys were sent out to patients seen by telehealth at the authors' academic center, and 122 responses were received. For the provider survey, 85 surveys were sent out to providers at the authors' center and other academic centers, and 40 surveys were received. Ninety-two percent of patients agreed or strongly agreed that they were satisfied with that particular telehealth visit. Eighty-eight percent of patients agreed that their telehealth visit was more convenient for them than an in-person visit, but only 36% of patients stated they would like their future visits to be telehealth. Sixty-three percent of providers agreed that telehealth visits were more convenient for them than in-person visits, and 85% of responding providers stated that they wished to incorporate telehealth into their future practice.
CONCLUSIONS: Although the authors' transition to telehealth was both rapid and unexpected, most providers and patients reported positive experiences with their telemedicine visits and found telemedicine to be an effective form of ambulatory neurosurgical care. Not all patients preferred telemedicine visits over in-person visits, but the high satisfaction with telemedicine by both providers and patients is promising to the future expansion of telehealth in ambulatory neurosurgery.

Entities:  

Keywords:  COVID-19; ambulatory; patient; provider; satisfaction; survey; telemedicine

Year:  2020        PMID: 33260126     DOI: 10.3171/2020.9.FOCUS20596

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  13 in total

1.  The Changing Nature of Telehealth Use by Primary Care Physicians in the United States.

Authors:  Timothy Callaghan; Carly McCord; David Washburn; Kirby Goidel; Cason Schmit; Tasmiah Nuzhath; Abigail Spiegelman; Julia Scobee
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

2.  Telemedicine use by neurosurgeons due to the COVID-19 related lockdown.

Authors:  Pravesh S Gadjradj; Roshni H S Matawlie; Biswadjiet S Harhangi
Journal:  Brain Spine       Date:  2021-12-04

3.  Physician, Nurse, and Advanced Practice Provider Perspectives on the Rapid Transition to Inpatient and Outpatient Telemedicine.

Authors:  Katherine A Meese; Allyson G Hall; Sue S Feldman; Alejandra Colón-López; David A Rogers; Jasvinder A Singh
Journal:  Telemed Rep       Date:  2022-01-10

4.  Telemedicine in Neurosurgery and Artificial Intelligence Applications.

Authors:  Mitch R Paro; William Lambert; Nathan K Leclair; Petronella Stoltz; Jonathan E Martin; David S Hersh; Markus J Bookland
Journal:  World Neurosurg       Date:  2022-04-21       Impact factor: 2.210

5.  Telehealth Adoption Across Neurosurgical Subspecialties at a Single Academic Institution During the COVID-19 Pandemic.

Authors:  Christopher Leung; Harsh Wadhwa; Matthew Sklar; Kunj Sheth; Sophia Loo; John Ratliff; Corinna C Zygourakis
Journal:  World Neurosurg       Date:  2021-03-18       Impact factor: 2.104

6.  Impact on neurosurgical management in Level 1 trauma centers during COVID-19 shelter-in-place restrictions: The Santa Clara County experience.

Authors:  Michael Zhang; James Zhou; Ben Dirlikov; Tene Cage; Marco Lee; Harminder Singh
Journal:  J Clin Neurosci       Date:  2021-04-04       Impact factor: 2.116

Review 7.  The Role of Telemedicine in Surgical Specialties During the COVID-19 Pandemic: A Scoping Review.

Authors:  Mahir Gachabayov; Lulejeta A Latifi; Afshin Parsikia; Rifat Latifi
Journal:  World J Surg       Date:  2021-11-06       Impact factor: 3.352

Review 8.  The Research on Patient Satisfaction with Remote Healthcare Prior to and during the COVID-19 Pandemic.

Authors:  Liliana Hawrysz; Grażyna Gierszewska; Agnieszka Bitkowska
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

9.  Telehealth Sustainability in a Neurosurgery Department During the COVID-19 Pandemic.

Authors:  Monica J Chau; Jorge E Quintero; Ashley Guiliani; Tripp Hines; Christopher Samaan; Katie Seybold; Matthew Stowe; Dean Hanlon; Greg A Gerhardt; Craig van Horne
Journal:  World Neurosurg       Date:  2021-06-12       Impact factor: 2.104

10.  The Utility of Remote Video Technology in Continuing Neurosurgical Care in the COVID-19 Era: Reflections from the Past Year.

Authors:  Akshay Sharma; Robert D Winkelman; Richard P Schlenk; Peter A Rasmussen; Lilyana Angelov; Deborah L Benzil
Journal:  World Neurosurg       Date:  2021-09-09       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.